According to the report of the Eurasian Patent Office (EAPO), in the first half of 2025, it received 20% more patent applications for inventions compared to the same period in 2024.
Eurasian applications for industrial designs showed an increase of 13%.
At the same time, the average term of the first effect within the framework of the substantive examination of inventions was 1.25 months.
In addition, the Eurasian Pharmaceutical Register was replenished with 26 patents.
The number of active Eurasian patents increased by 3%.
The activity of patent owners from China in maintaining Eurasian patents increased by 22%.